Mechanisms of SEMA4D mediated breast cancer to brain metastasis

SEMA4D介导乳腺癌脑转移的机制

基本信息

批准号：
10442375
负责人：
Min Yu
金额：
$ 36.99万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-07-01 至 2023-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10442375
关键词：
Alanine Binding Biological Assay Blood Blood - brain barrier anatomy Blood Circulation Brain Breast Cancer Cell Breast Cancer Patient CD100 antigen CRISPR/Cas technology Cathepsins Cell Polarity Cells Co-Immunoprecipitations Complex Complication Cytoplasm Cytoplasmic Tail Data Development Epithelial In Vitro Incidence Interruption Knock-out Knockout Mice Knowledge Ligands Ligation Link Malignant Neoplasms Malignant neoplasm of lung Mediating Metastatic malignant neoplasm to brain Modeling Molecular Morbidity - disease rate Mutate Nature Neoplasm Circulating Cells PDZ protein Pathway interactions Patients Peptides Phosphorylation Proteins Publishing Regulation Research Resources Role Sampling Serine Signal Transduction Stream Surface Systemic Therapy Testing Therapeutic Tight Junctions blood-brain barrier crossing blood-brain tumor barrier brain endothelial cell cancer type cell motility connective tissue growth factor design in vivo malignant breast neoplasm mortality mouse model mutant neoplastic cell overexpression patient prognosis predictive marker prevent protein complex receptor small hairpin RNA synergism targeted treatment tumor

项目摘要

Summary Brain metastasis accounts for significant morbidity and mortality of many cancer types, the two most common being lung and breast cancers. This devastating complication is initiated by a rare subset of the circulating tumor cells (CTCs) shed into the blood stream. The crossing of the blood-brain barrier (BBB) by CTCs is the first critical step that initiates brain metastasis. Thus, understanding how CTCs can breach the BBB is critical for developing means to predict, prevent, or treat brain metastasis. Our recent study using ex vivo expanded CTCs isolated from breast cancer patients identified a transmembrane surface receptor, SEMA4D, promotes brain metastasis by enabling CTCs to cross the BBB via binding to its ligand PLXNB1 on the brain endothelial cells (BECs). Our preliminary data now show that SEMA4D stimulation leads to YAP/TAZ signaling in tumor cells, a pathway well known to promote cell motility and migration, and recently implicated in the development of brain metastasis. Therefore, we hypothesize a role for “reverse signaling” through the SEMA4D cytoplasmic tails to activate YAP signaling for synergizing with SEMA4D-PLXNB1 tethering to the BECs to breach the BBB. We will utilize our unique resources of patient-derived CTCs, and in vitro and in vivo BBB transmigration assays to test our hypothesis. The overall objective of this proposal is to dissect the detailed mechanisms linking SEMA4D to YAP signaling, and the role for YAP in SEMA4D-mediated BBB transmigration. Delineating the combinatory effect of SEMA4D and YAP signaling will allow us to design potential therapeutic approaches to prevent SEMA4D-mediated brain metastasis. Such knowledge will also provide a mechanistic basis for identifying additional BBB transmigration initiators that could act similarly through receptor tethering to BECs and subsequent activation of YAP, which could have a broader impact on identifying predictive biomarkers for brain metastasis.

概括脑转移是许多癌症类型的显着发病率和死亡率，这两种最常见的是肺和野兽癌。这种毁灭性的并发症是由循环的罕见子集引发的肿瘤细胞（CTC）流入血液中。 CTC的血脑屏障（BBB）的穿越是启动大脑转移的第一步。那就了解CTC如何违反BBB至关重要用于预测，预防或治疗脑转移的手段。我们最近使用Ex Vivo的研究扩展了从乳腺癌患者中分离出的CTC鉴定出跨膜表面受体SEMA4D促进脑转移通过使CTC通过在脑内皮上与其配体PLXNB1结合越过BBB 细胞（BEC）。我们的初步数据现在表明，SEMA4D刺激导致肿瘤中的YAP/TAZ信号传导细胞是一种众所周知的途径，可促进细胞运动和迁移，并在发育中实施脑转移。因此，我们假设通过SEMA4D“反向信号”的角色细胞质尾巴激活YAP信号传导，以与SEMA4D-PLXNB1协同为BEC将违反BBB。我们将利用患者来源的CTC的独特资源，体外和体内BBB 转移测定法以检验我们的假设。该提案的总体目的是剖析详细的将SEMA4D与YAP信号联系起来的机制，以及YAP在SEMA4D介导的BBB传输中的作用。描述SEMA4D和YAP信号的组合效应将使我们能够设计潜在的治疗性预防SEMA4D介导的脑转移的方法。这样的知识还将提供机械识别其他BBB迁移启动者的基础，这些启动者可以通过受体束缚到 BEC和随后的YAP激活，这可能会对识别预测有更广泛的影响脑转移的生物标志物。